You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

IOPIDINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Iopidine, and what generic alternatives are available?

Iopidine is a drug marketed by Harrow Eye and is included in two NDAs.

The generic ingredient in IOPIDINE is apraclonidine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apraclonidine hydrochloride profile page.

US Patents and Regulatory Information for IOPIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Harrow Eye IOPIDINE apraclonidine hydrochloride SOLUTION/DROPS;OPHTHALMIC 020258-001 Jul 30, 1993 AT RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Harrow Eye IOPIDINE apraclonidine hydrochloride SOLUTION/DROPS;OPHTHALMIC 019779-001 Dec 31, 1987 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for IOPIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Harrow Eye IOPIDINE apraclonidine hydrochloride SOLUTION/DROPS;OPHTHALMIC 019779-001 Dec 31, 1987 ⤷  Sign Up ⤷  Sign Up
Harrow Eye IOPIDINE apraclonidine hydrochloride SOLUTION/DROPS;OPHTHALMIC 020258-001 Jul 30, 1993 ⤷  Sign Up ⤷  Sign Up
Harrow Eye IOPIDINE apraclonidine hydrochloride SOLUTION/DROPS;OPHTHALMIC 019779-001 Dec 31, 1987 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for IOPIDINE

See the table below for patents covering IOPIDINE around the world.

Country Patent Number Title Estimated Expiration
Netherlands 950008 ⤷  Sign Up
Japan S58116417 METHOD OF LOWERING INTRAOCULAR PRESSURE ⤷  Sign Up
Canada 1194418 COMPOSITIONS A BASE DE 2-(PHENYLIMINO TRISUBSTITUE)- IMIDAZOLINE POUR L'ABAISSEMENT DE LA PRESSION INTRAOCULAIRE (2-(TRISUBSTITUTED PHENYLIMINO)-IMIDAZOLINE COMPOSITIONS FOR LOWERING INTRAOCULAR PRESSURE) ⤷  Sign Up
Japan H0453846 ⤷  Sign Up
Germany 3269242 ⤷  Sign Up
Canada 1201066 SOLUTIONS DE N-[3,5-DICHLORO-4-(2- IMIDAZOLIDINYLIDENE-AMINO)-PHENYL]-ACETAMIDE POUR DIMINUER LA PRESSION INTRA-OCULAIRE (N-[3,5-DICHLORO-4-(2-IMIDAZOLIDINYLIDENEAMINO)- PHENYL]-ACETAMIDE SOLUTIONS FOR LOWERING INTRAOCULAR PRESSURE) ⤷  Sign Up
Austria 18006 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for IOPIDINE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0081924 SPC/GB93/103 United Kingdom ⤷  Sign Up SPC/GB93/103:, EXPIRES: 20071118
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.